Rosen Law Firm Initiates Securities Investigation Into Lufax Following Auditor Removal

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Rosen Law Firm investigates Lufax for potential securities violations after the fintech company removed auditors and delayed its annual report, causing stock to plunge 13.8%.

Rosen Law Firm Initiates Securities Investigation Into Lufax Following Auditor Removal

The Rosen Law Firm has announced an investigation into potential securities violations by Lufax Holding Ltd (NYSE: LU) following significant developments disclosed on January 27, 2025. The fintech company announced the removal of its auditors and delayed publication of its 2024 annual report, triggering an immediate market reaction that saw the stock decline 13.8% on the announcement.

The law firm is examining whether Lufax's public disclosures contained materially misleading information regarding its business operations and financial condition. Such auditor changes and reporting delays typically warrant investor scrutiny, as they may indicate underlying accounting or governance concerns that were not previously disclosed to shareholders.

The investigation is being pursued with the potential for a class action lawsuit, which would seek to recover losses sustained by shareholders during the period when the allegedly misleading information was in circulation. Investors who experienced losses in Lufax securities are being encouraged to contact the firm to discuss potential claims and legal remedies.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 20

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON